Advanced Biomedical Ultrasound Imaging and Therapy Laboratory

Authors

  • Jahan Tavakkoli Dept. of Physics, Ryerson University Toronto, Ontario
  • Raffi Karshafian
  • Michael C. Kolios

Keywords:

biomedical ultrasound, ultrasound imaging, therapy, and simulation, photoacoustic imaging, ultrasound drug delivery

Abstract

The Advanced Biomedical Ultrasound Imaging and Therapy Laboratory (ABUITL), a 1600 square-foot research laboratory jointly affiliated to Ryerson University and St. Michael’s Hospital, is one of the leading research laboratories in the field of biomedical ultrasound in Canada. The laboratory was established in 2007 in the Dept. of Physics, Ryerson University and was relocated to iBEST (Institute for Biomedical Engineering, Science and Technology) in St. Michael’s Hospital in September 2015. The laboratory hosts an array of research equipment in diagnostic and therapeutic biomedical ultrasound and has been active in conducting research and development and the training of highly qualified personnel (HQP) in the field. The scope of the research projects in the laboratory spans from ultrasound basic science and the investigation of biophysical mechanisms of the interactions of ultrasound with cells and tissues to novel clinical applications in all main areas of biomedical ultrasound.

Author Biography

Jahan Tavakkoli, Dept. of Physics, Ryerson University Toronto, Ontario

Associate Professor of Biomedical Physics

Downloads

Published

2016-05-30

How to Cite

1.
Tavakkoli J, Karshafian R, Kolios MC. Advanced Biomedical Ultrasound Imaging and Therapy Laboratory. Canadian Acoustics [Internet]. 2016 May 30 [cited 2023 Mar. 31];44(2):50-1. Available from: https://jcaa.caa-aca.ca/index.php/jcaa/article/view/2832

Issue

Vol. 44 No. 2 (2016)

Section

Special Issue

License

Copyright on articles is held by the author(s). The corresponding author has the right to grant on behalf of all authors and does grant on behalf of all authors, a worldwide exclusive licence (or non-exclusive license for government employees) to the Publishers and its licensees in perpetuity, in all forms, formats and media (whether known now or created in the future)
i)    to publish, reproduce, distribute, display and store the Contribution;
ii)    to translate the Contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or, abstracts of the Contribution;
iii)    to exploit all subsidiary rights in the Contribution,
iv)    to provide the inclusion of electronic links from the Contribution to third party material where-ever it may be located;
v)    to licence any third party to do any or all of the above.